Filter by: patients
Home > Community Treatment Reports and Side Effects > Abacavir-Lamivudine Treatment Report
What is Abacavir-Lamivudine?

Abacavir and lamivudine are antiretroviral agents. Both of these medicines are nucleoside reverse transcriptase inhibitors (NRTIs). The combination of abacavir and lamivudine is used for the treatment of HIV infections in combination with other antiretroviral agents.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 109 26 Efficacy_major Efficacy_moderate Efficacy_cant_tell
Support immune health 3 1 Efficacy_major
Increase effect of another treatment 2 2 Efficacy_major
Fatigue 2 1 Efficacy_moderate
AIDS (Acquired Immune Deficiency Syndrome) 1 0
Other 1 1 Efficacy_none

See all 122 patients currently taking Abacavir-Lamivudine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 4
Mild
 9
None
 16

Commonly reported side effects, conditions, and hospitalizations associated with Abacavir-Lamivudine

Fatigue 6
Anxious mood 4
Lipodystrophy (lipoatrophy or loss of fatty tissue) 3
Panic attacks 3
Pain in gums 1
Tooth (dental) pain 1
See all 7 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Abacavir-Lamivudine. See all 16 dosages ►

  daily 1 daily 6 mg daily 600 mg-300 mg monthly 200 mg daily 300 mg daily 600 mg daily 600 mg-300 mg daily 900 mg daily 2 x 600 mg-300 mg daily
  5 Number of Patients: 5 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 7 Number of Patients: 7 83 Number of Patients: 83 6 Number of Patients: 6 5 Number of Patients: 5  

Reported Stop Reasons

Why Patients Stopped Taking Abacavir-Lamivudine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 6   Side effects too severe: 32%
Doctor's advice 5   Doctor's advice: 26%
Other 5   Other: 26%
Personal research 2   Personal research: 11%
Did not seem to work 1   Did not seem to work: 5%
Expense 1   Expense: 5%
Course of treatment ended 1   Course of treatment ended: 5%

See all 18 patients who’ve stopped taking Abacavir-Lamivudine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Abacavir-Lamivudine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Abacavir-Lamivudine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Abacavir-Lamivudine

Always
 27 87%
Usually
 3 10%
Sometimes
 0 0%
Never
 1 3%

Burden

Difficulty being on treatment

Burden of Abacavir-Lamivudine

Very
 1 3%
Somewhat
 1 3%
A little
 8 26%
Not at all
 21 68%

Cost

Paid out of pocket

Cost of Abacavir-Lamivudine

$200+
 0 0%
$100-199
 0 0%
$50-99
 2 13%
$25-49
 4 27%
< $25
 9 60%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.